文献
J-GLOBAL ID:201802250533281507
整理番号:18A0345237
プロテアーゼ活性化受容体-2(PAR 2)の発現は卵巣明細胞腺癌における進行性臨床病期と予後不良に関連している【Powered by NICT】
Expression of protease-activated receptor-2 (PAR-2) is related to advanced clinical stage and adverse prognosis in ovarian clear cell carcinoma
著者 (7件):
Aman Murasaki
(Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka 812-8582, Japan)
,
Ohishi Yoshihiro
(Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka 812-8582, Japan)
,
Imamura Hiroko
(Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka 812-8582, Japan)
,
Shinozaki Tomoko
(Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka 812-8582, Japan)
,
Yasutake Nobuko
(Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka 812-8582, Japan)
,
Kato Kiyoko
(Department of Gynecology and Obstetrics, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka 812-8582, Japan)
,
Oda Yoshinao
(Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka 812-8582, Japan)
資料名:
Human Pathology
(Human Pathology)
巻:
64
ページ:
156-163
発行年:
2017年
JST資料番号:
E0614C
ISSN:
0046-8177
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)